1Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination[J]. Virus Res, 2004, 103 (1-2):133-138.
2Fouchier RA, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls [J]. J Virol, 2005, 79 (5): 2814-2822.
3Lee M, Chen JS. Predicting antigenic variants of influenza A/ H3N2 viruses [J]. Emerge Infect Dis, 2004, 10(8):1385-1390.
4World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2004-2005 influenza season [J]. WKLY Epidemiol Rec, 2004, 79 (9): 88-92.
7Katz JM. The impact of avian influenza viruses on public health[J]. Avian Dis, 2003, 47(Suppl 3):S914-S920.
8李兴旺.人禽流感的临床诊治[N].医师报,2007-06-30.
9WHO. Cumulative number of confirmed human eases of avian influenza A(H5N1) reported to WHO [EB/OL].[2007-10-31]. http://www.who.int/csr/disease/avian_influenza/country/cases_table_2007_10_31/en/index.html.
10Normile D. Infectious diseases. Genetic analyses suggest bird flu vires is evolving [J]. Science, 2005, 308(5726):1234-1235.
2Holmes EC. Virology. 1918 and all that [J]. Science,2034,303(5665) : 1787 - 1788.
3Layne SP, Beugelsdijk TJ, Patel CK, et al. A global lab against influenza[J]. Science ,2001,293(5536) : 1729.
4Wang J, Kim S, Kovacs F, et al. Structure of the transmembrane region of the M2 protein H^+ channel [ J ]. Protein Sci,2001,10( 11 ) :2241 - 2250.
5Kelly ML, Cook JA, Brown-Augsburger P, et al. Demonstrafing the intrinsic ion channel activity of vitally encoded proteins[J]. FEBS Lett,2003,552(1) :61 - 67.
6Salom D, Hill BR, lear JD, et al. pH-Dependent tetramerization and amantadine binding of the tmnsmembrane helix of M2 from the influenza A virus[J]. Biochemistry,2000,39(46) : 14160 - 14170.
7Jefferson T, Deeks J, Demicheli V, et al. Amantadine and rimantadine for preventing and treating influenza A in adults[J]. Cochrane Database Syst Rev,2004,(3) :CD001169.
8Saito R,Sakai T, Sato I, et al. Frequency of amantadine-resistant influenza A viruses during two seasons featuring cocirculation of H1N1 and H3N2[J]. J Clin Microbiol,2003,41(5) :2164 - 2165.
9Astrahan P, Kass I, Cooper MA, et al. A novel method of resistance for influenza against a channel-blocking antiviral drug[J]. Proteins,2004,55(2) :251 - 257.
